PTC Therapeutics
PTCT
PTCT
129 hedge funds and large institutions have $715M invested in PTC Therapeutics in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
+15
Holders Change %
+13.16%
% of All Funds
3.22%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
29
Increased
53
Reduced
32
Closed
13
Calls
$41.2M
Puts
$86.1M
Net Calls
-$44.9M
Net Calls Change
-$54.1M
Top Buyers
1 |
SCM
Scopia Capital Management
New York
|
$23.9M |
2 |
DAM
DLD Asset Management
New York
|
$12.3M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$58.7M |
4 |
NI
Numeric Investors
Boston,
Massachusetts
|
$9.42M |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
$23.2M |